Integer Holdings Co. (NYSE:ITGR) Shares Purchased by Lord Abbett & CO. LLC

Lord Abbett & CO. LLC raised its position in Integer Holdings Co. (NYSE:ITGR - Free Report) by 3.5% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 290,120 shares of the medical equipment provider's stock after buying an additional 9,754 shares during the quarter. Lord Abbett & CO. LLC owned about 0.86% of Integer worth $37,716,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of the company. TD Private Client Wealth LLC boosted its stake in shares of Integer by 15.5% in the third quarter. TD Private Client Wealth LLC now owns 1,420 shares of the medical equipment provider's stock valued at $185,000 after buying an additional 191 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Integer by 1.2% in the third quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider's stock valued at $99,408,000 after acquiring an additional 9,421 shares during the period. Public Employees Retirement System of Ohio boosted its position in shares of Integer by 3,443.4% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 13,890 shares of the medical equipment provider's stock worth $1,806,000 after purchasing an additional 13,498 shares in the last quarter. XTX Topco Ltd grew its stake in shares of Integer by 31.5% during the 3rd quarter. XTX Topco Ltd now owns 6,764 shares of the medical equipment provider's stock worth $879,000 after purchasing an additional 1,620 shares during the period. Finally, Jane Street Group LLC increased its holdings in shares of Integer by 23.3% in the 3rd quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider's stock valued at $19,682,000 after purchasing an additional 28,572 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

Integer Trading Down 0.4 %

NYSE:ITGR traded down $0.58 on Friday, reaching $138.71. The stock had a trading volume of 155,806 shares, compared to its average volume of 303,022. The company has a market cap of $4.65 billion, a price-to-earnings ratio of 42.81, a P/E/G ratio of 2.02 and a beta of 1.12. Integer Holdings Co. has a 12-month low of $94.56 and a 12-month high of $142.76. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. The firm's fifty day moving average is $133.78 and its two-hundred day moving average is $125.75.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating the consensus estimate of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The firm had revenue of $431.42 million during the quarter, compared to analyst estimates of $440.59 million. During the same period in the prior year, the firm posted $1.27 earnings per share. The business's quarterly revenue was up 8.7% compared to the same quarter last year. Equities analysts expect that Integer Holdings Co. will post 5.33 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have weighed in on ITGR. Wells Fargo & Company restated an "overweight" rating and set a $160.00 target price on shares of Integer in a research report on Tuesday, December 3rd. KeyCorp raised their price objective on Integer from $139.00 to $144.00 and gave the company an "overweight" rating in a research note on Tuesday, October 15th. Truist Financial boosted their target price on Integer from $147.00 to $163.00 and gave the stock a "buy" rating in a research report on Wednesday. Piper Sandler restated an "overweight" rating and issued a $140.00 price target (up previously from $125.00) on shares of Integer in a research report on Friday, October 25th. Finally, Bank of America lifted their price target on Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a research note on Tuesday, October 1st. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $145.44.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.